Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000701043 | SCV000829825 | uncertain significance | Congenital myasthenic syndrome 4A | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 352 of the CHRNE protein (p.Arg352Leu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 578125). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHRNE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Gene |
RCV001771988 | SCV002002353 | uncertain significance | not provided | 2020-07-17 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
| Mayo Clinic Laboratories, |
RCV001771988 | SCV005412609 | uncertain significance | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | |
| Natera, |
RCV001825378 | SCV002093393 | uncertain significance | Congenital myasthenic syndrome | 2020-11-06 | no assertion criteria provided | clinical testing |